OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection
Adam Stafford, Stephanie Rimmer, Mark Gilchrist, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. e218-e226
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
Thomas Smith, Crystal M. Gigante, Nhien T. Wynn, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 12
Open Access | Times Cited: 60

Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta‐analysis
Hyoin Shin, Heeje Shin, Masoud Rahmati, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 25

Mpox outbreak—tecovirimat resistance, management approaches, and challenges in HIV-endemic regions
Wyvine Ansima Bapolisi, Susanne Krasemann, Misaki Wayengera, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. e672-e673
Closed Access | Times Cited: 9

Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications
Carmela Pinnetti, Eleonora Cimini, Valentina Mazzotta, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 2, pp. e127-e135
Open Access | Times Cited: 21

Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review
Giuseppe Bruno, Giovanni Battista Buccoliero
Life (2023) Vol. 13, Iss. 10, pp. 1969-1969
Open Access | Times Cited: 18

Mpox: The Reemergence of an Old Disease and Inequities
John Thornhill, Monica Gandhi, Chloe Orkin
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 159-175
Open Access | Times Cited: 17

Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review
Nadim Sharif, Nazmul Sharif, Khalid J. Alzahrani, et al.
Health Science Reports (2023) Vol. 6, Iss. 10
Open Access | Times Cited: 17

Mpox in people with HIV: A narrative review
Hideta Nakamura, Kazuko Yamamoto
HIV Medicine (2024) Vol. 25, Iss. 8, pp. 910-918
Open Access | Times Cited: 6

Update on Mpox: a brief narrative review.
Spinello Antinori, Giacomo Casalini, Andrea Giacomelli, et al.
PubMed (2023) Vol. 31, Iss. 3, pp. 269-276
Closed Access | Times Cited: 16

Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report
Andrés Martínez, Paola Frattaroli, Christine Vu, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 650-650
Open Access | Times Cited: 13

Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
Jérémie Prévost, Angela Sloan, Yvon Deschambault, et al.
Antiviral Research (2024) Vol. 231, pp. 105995-105995
Open Access | Times Cited: 5

Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection
Julia C Fortier, Christopher Marsalisi, Elian Cordova, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 4

A brief synopsis of mpox
Heidi M Torres
Elsevier eBooks (2025), pp. 3-19
Closed Access

Treating concomitant human immunodeficiency virus and monkeypox virus infection
Natasha N. Pettit, Renslow Sherer, Sabrina Imam, et al.
Elsevier eBooks (2025), pp. 473-491
Closed Access

Time-related change in mpox (monkeypox) skin lesions and their progression
Yeimer Ortiz-Martínez, Andrés F. Henao‐Martínez
Elsevier eBooks (2025), pp. 269-290
Closed Access

Mpox: Global epidemic situation and countermeasures
Wen-Shuang Hou, Nan Wu, Yanzhi Liu, et al.
Virulence (2025) Vol. 16, Iss. 1
Open Access

Repurposing doxycycline for the inhibition of monkeypox virus DNA polymerase: a comprehensive computational study
Muhammad Abrar Yousaf, Maurice Michel, Abeedha Tu-Allah Khan, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access

Atypical Mpox Cutaneous Presentation After Full Vaccination
Celine M. Schreidah, Blair A. Jenkins, Megan H. Trager, et al.
American Journal of Dermatopathology (2025)
Closed Access

Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics
N. Sanoj Rejinold, Geun‐woo Jin, Jin‐Ho Choy
Advanced Healthcare Materials (2025)
Open Access

Mpox impact on different organ systems: Complications, mechanisms, and management
Abdullah Reda, Kuldeep Dhama
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Open Access | Times Cited: 10

Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients
Michael Tran Duong, Pablo Tebas, Bhavya Ancha, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 3

Mpox Recurrence and Tecovirimat Resistance in a Patient with Advanced HIV Disease
David C Griffith, Amary Fall, Mihaela Carter, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 3

Mpox and HIV—Collision of Two Diseases
Jason Zucker, Aniruddha Hazra, Boghuma K Titanji
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 6, pp. 440-450
Closed Access | Times Cited: 7

Intriguing insight into unanswered questions about Mpox: exploring health policy implications and considerations
Emery Manirambona, Sheharyar Hassan Khan, Abdelmonem Siddiq, et al.
Health Research Policy and Systems (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top